Savara (SVRA) Return on Capital Employed Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 68,255.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 2,665.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 31,429.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2,503.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -105.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,400.00
10 Savara 1.30 Bn 1.30 Bn - -271.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -271.00
Dec 31, 2025 -2,101.00
Sep 30, 2025 -3,866.00
Jun 30, 2025 -1,300.00
Mar 31, 2025 -1,319.00
Dec 31, 2024 -1,342.00
Sep 30, 2024 -1,330.00
Jun 30, 2024 -2,054.00
Mar 31, 2024 -1,141.00
Dec 31, 2023 -730.00
Sep 30, 2023 -1,126.00
Jun 30, 2023 -1,442.00
Mar 31, 2023 -788.00
Dec 31, 2022 -337.00
Sep 30, 2022 -204.00
Jun 30, 2022 -137.00
Mar 31, 2022 467.00
Dec 31, 2021 2,690.00
Sep 30, 2021 4,061.00
Jun 30, 2021 3,977.00
Mar 31, 2021 3,853.00
Dec 31, 2020 1,027.00
Sep 30, 2020 -2,003.00
Jun 30, 2020 -1,847.00
Mar 31, 2020 -3,244.00
Dec 31, 2019 -1,414.00
Sep 30, 2019 796.00
Jun 30, 2019 760.00
Mar 31, 2019 528.00
Dec 31, 2018 -2,535.00
Sep 30, 2018 -3,149.00
Jun 30, 2018 -1,697.00
Mar 31, 2018 5,344.00
Dec 31, 2017 1,275.00
Sep 30, 2017 5,099.00
Jun 30, 2017 6,392.00
Mar 31, 2017 1,175.00
Dec 31, 2016 7,519.00
Sep 30, 2016 722.00
Jun 30, 2016 -2,694.00
Mar 31, 2016 -5,057.00
Dec 31, 2015 -5,709.00
Sep 30, 2015 -2,445.00
Jun 30, 2015 -2,624.00
Mar 31, 2015 -1,259.00
Dec 31, 2014 -1,240.00
Sep 30, 2014 -2,068.00
Jun 30, 2014 -968.00
Mar 31, 2014 -219.00
Dec 31, 2013 -747.00
Sep 30, 2013 -634.00
Jun 30, 2013 -877.00
Mar 31, 2013 -1,586.00
Dec 31, 2012 -750.00
Sep 30, 2012 142.00